EP 0973881 A2 20000126 - MYCOBACTERIUM RECOMBINANT VACCINES
Title (en)
MYCOBACTERIUM RECOMBINANT VACCINES
Title (de)
IMPFSTOFFE AUS REKOMBINANTEN MYCOBAKTERIEN
Title (fr)
VACCINS RECOMBINES A BASE DE MYCOBACTERIES
Publication
Application
Priority
- US 9806056 W 19980327
- US 4284997 P 19970328
Abstract (en)
[origin: WO9844096A2] Mycobacterium recombinant vaccines for treatment of intracellular diseases have been developed utilizing an antigen delivery system in the form of Mycobacterium strains, a genetic transfer system in the form of cloning nonpathogenic and expression vectors, and related technologies to provide products combining nontoxic immuno-regulating Mycobacterium adjuvants, nontoxic immuno-stimulating exogenous antigens specific for a variety of diseases, and nontoxic amounts of cytokines that boost the TH-1 pathway. Cloning and expression Mycobacterium vectors include both extra-nuclear and integrative vectors.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 35/74 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/04 (2006.01); A61K 39/21 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C12N 15/74 (2006.01); C12R 1/32 (2006.01)
CPC (source: EP)
A61K 39/04 (2013.01); A61P 35/00 (2017.12); C12N 15/74 (2013.01); A61K 2039/522 (2013.01); A61K 2039/523 (2013.01)
Citation (search report)
See references of WO 9844096A2
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9844096 A2 19981008; WO 9844096 A3 19990114; AU 6780498 A 19981022; BR 9808441 A 20000523; CA 2284736 A1 19981008; EP 0973881 A2 20000126; JP 2001518781 A 20011016
DOCDB simple family (application)
US 9806056 W 19980327; AU 6780498 A 19980327; BR 9808441 A 19980327; CA 2284736 A 19980327; EP 98913194 A 19980327; JP 54183198 A 19980327